This inventor holds 5 USPTO granted patents and 14 published patent applications and 5 EPO patents. Top assignees: Xiamen Sinopeg Biotech Co., Ltd., Xiamen Sinopeg Biotech, Ltd.. Active years: 2019-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2026
Title: Innovations of Wengui Weng in Biotech
Introduction
Wengui Weng is a notable inventor based in Xiamen, China. He has made significant contributions to the field of biotechnology, particularly in the development of polyethylene glycol derivatives. With a total of 5 patents, his work showcases innovative approaches to enhancing the functionality and applicability of these compounds.
Latest Patents
Weng's latest patents include a multifunctionalized polyethylene glycol derivative and its preparation method. This invention features an H-shaped structure that comprises one linear core and four PEG branch chains. The derivative is designed to be flexible and diverse, allowing for adjustable performance indicators and broad applicability. Another significant patent is the eight-arm polyethylene glycol derivative, which includes a highly symmetric octavalent central structure. This design enhances the drug loading capacity and allows for precise control over molecular weight during production.
Career Highlights
Wengui Weng is currently associated with Xiamen Sinopeg Biotech Co., Ltd., where he continues to innovate in the field of biotechnology. His work has not only advanced the understanding of polyethylene glycol derivatives but has also contributed to the development of modified bio-related substances with uniform and controllable performance.
Collaborations
Weng has collaborated with notable coworkers such as Chao Liu and Ce Yan, further enhancing the research and development efforts at his company.
Conclusion
Wengui Weng's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing the field. His work on polyethylene glycol derivatives has the potential to impact various applications in pharmaceuticals and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile